| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2024 | DHR Danaher Corp /de/ | Ellis Brian W62 | Senior Vice President - GC | Sell | 4,000 | $250.01 | $1,000,040.00 | -11.8% | +5.5% | -21.5% | |
| Apr 23, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 522 | $91.38 | $47,699.94 | -0.5% | +15.9% | +63.2% | |
| Apr 23, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 531 | $91.38 | $48,522.36 | -0.5% | +15.9% | +63.2% | |
| Apr 23, 2024 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,174 | $30.12 | $65,483.05 | -1.2% | +78.5% | +19.4% | |
| Apr 23, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 1,126 | $20.11 | $22,642.73 | -0.4% | -0.8% | +6.0% | |
| Apr 23, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,523 | $91.38 | $139,170.52 | -2.0% | +15.9% | +63.2% | |
| Apr 23, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 787 | $91.38 | $71,915.43 | -0.4% | +15.9% | +63.2% | |
| Apr 23, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,552 | $91.38 | $233,199.72 | -1.1% | +15.9% | +63.2% | |
| Apr 16, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 80,000 | $90.82 | $7,265,651.29 | -21.7% | +24.7% | +66.3% | |
| Apr 15, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,816 | $93.13 | $634,797.37 | -1.0% | +24.6% | +67.8% | |
| Apr 12, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,210 | $20.35 | $106,023.50 | -1.9% | -7.8% | -1.8% | |
| Apr 11, 2024 | IMDX Insight Molecular Diagnostics Inc. | Riggs Josh | CEO And President | Buy | 3,390 | $2.95 | $10,000.50 | +2,948% | +1.9% | -6.2% | |
| Apr 11, 2024 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 2,420,000 | $2.92 | $7,057,688.00 | +32.5% | +1.9% | -6.2% | |
| Apr 11, 2024 | IMDX Insight Molecular Diagnostics Inc. | Arno Andrew | Director | Buy | 33,898 | $2.95 | $99,999.10 | +96.4% | +1.9% | -6.2% | |
| Apr 9, 2024 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 556 | $33.16 | $18,434.18 | -0.7% | +45.1% | +19.4% | |
| Apr 8, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 2,400 | $20.45 | $49,087.20 | -3.0% | -14.0% | -10.8% | |
| Apr 5, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 20,923 | $21.12 | $441,853.46 | -10.8% | -16.4% | -10.8% | |
| Apr 3, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 6,336 | $21.70 | $137,491.20 | -2.3% | -1.3% | -10.9% | |
| Apr 3, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 26,700 | $92.47 | $2,468,821.52 | -2.6% | +19.5% | +49.8% | |
| Apr 2, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 129 | $32.74 | $4,222.94 | -0.2% | +48.6% | +16.1% | |
| Apr 2, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,378 | $92.62 | $127,628.98 | -1.9% | +17.3% | +55.8% | |
| Apr 2, 2024 | TWST Twist Bioscience Corp | Banyai William81 | See Remark | Sell | 327 | $32.74 | $10,704.67 | - | +48.6% | +16.1% | |
| Apr 2, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 229 | $32.74 | $7,496.54 | -0.2% | +48.6% | +16.1% | |
| Apr 2, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 1,132 | $32.74 | $37,057.15 | -0.2% | +48.6% | +16.1% | |
| Apr 2, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | EVP, Gm., Precision Oncology | Sell | 924 | $79.43 | $73,393.32 | -6.6% | -42.5% | -39.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.